Authors:
Schmitt, A
Maras, A
Petroianu, G
Braus, DF
Scheuer, L
Gattaz, WF
Citation: A. Schmitt et al., Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophrenia, J NEURAL TR, 108(8-9), 2001, pp. 1081-1091
Authors:
Silva, JACE
Alvarez, N
Mazzotti, G
Gattaz, WF
Ospina, J
Larach, V
Starkstein, S
Oliva, D
Cousins, L
Tohen, M
Taylor, CC
Wang, J
Tran, PV
Citation: Jace. Silva et al., Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: Results of a multicenter, collaborative trial in Latin America, J CL PSYCH, 21(4), 2001, pp. 375-381
Authors:
Frieboes, RM
Moises, HW
Gattaz, WF
Yang, L
Li, T
Liu, XH
Vetter, P
Macciardi, F
Hwu, HG
Henn, F
Citation: Rm. Frieboes et al., Lack of association between schizophrenia and the phospholipase-A(2) genescPLA2 and sPLA2, AM J MED G, 105(3), 2001, pp. 246-249
Authors:
Eckert, GP
Cairns, NJ
Maras, A
Gattaz, WF
Muller, WE
Citation: Gp. Eckert et al., Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: Specific changes in Alzheimer's disease, DEMENT G C, 11(4), 2000, pp. 181-186
Authors:
Schredl, M
Weber, B
Braus, D
Gattaz, WF
Berger, M
Riemann, D
Heuser, I
Citation: M. Schredl et al., The effect of rivastigmine on sleep in elderly healthy subjects (vol 35, pg 243, 2000), EXP GERONT, 35(8), 2000, pp. 1105-1105